Member Info for RorkesDrift

Energy shares :-).

Https://ir.corbuspharma.com/press-releases/detail/402/crb-701-sys6002-a-next-generation-nectin-4-targeting

Non issue raised by the tw4tterati who then just amplify it as if 4 people repeating nonsense is evidence. You either believe management are capable and the Dx strategy is brilliance in the making and therefore their ability adds value to therapeutics. The alternative is they have thrown away millions in hard needed cash and don't have the smarts required by Tx and should be replaced. The pom pom guys would have us belive losing millions on a vanity project is excellent justification for believing they can make them all rich. Management would be resigning if they went down that path. Sometimes when you have nothing to say then shut up rather than just putting stuff into the magic calculator and parroting it.

The company have stated they will have cash required soon. They state that deals on precision are in the making.

No worries.

Https://iwgtfy.com/?q=Doxorubicin+cost

Pseudoscience ---- from the child with the crayons.

Careful you don't fall from your self erected pedestal

Oh hang on I've just checked the slides on the Avacta website and it's too late. Managed to miss the key data and none of your insight actually happened. Oh dear. Same science brilliance that led you to pump 4D pharma and your mining shares. Data is in and doesn't look great for you.

I get that SP is right for a bit of pump and dump - poetic that you are back. Try being humble. You have a lot.....

Did you see what I did there :-)

Bring back the timeline. Oh and the funny graph done with crayons. Now the self help circle has booted out the over enthusiastic thrashing, twitter is overwhelmed by pom pom girls and the need for pantomime donkeys is over for another year, we can expect more self pitying clip clop of tiny man hooves.

If only there was some way of commercialising the IP inherent in affimer technology the SP could respond. I just hope that Avacta don't try and rush this to market and in so doing jeopardise the chance of further posters in basic science journals.

It's still a log scale. Cmax and AUC differences are huge. Not sure if this discussion reflects true numbers.

The pk graph is on a log scale.

Https://youtu.be/MVk6Ut1N9AM?si=OO8q0IvZTOYebqPc

Thx for posting

Thx for posting

Https://www.mcdonalds.com/gb/en-gb/menu/breakfast.html

It involves Opelia and she ends up going loopy

Oh no he doesn't

Are we playing name the pantomime dame?

Agreed. In my mind some people are buying, some are selling.

Oh hang on.....

Manufactured by whom?

My reference to patents is related to affimers

We were meant to get a widely promoted Dx update in summer. This was cancelled. Attendees reported that product launch was cancelled due to patent issues. Result we have bought two Dx companies with no synergy rather than a channel to launch affimer Dx.

Extension of trial. Compare to original timeline and the minimal amount of data emerging. Most of us hold fast but other SH are waiting for something more substantial. In meantime time and money dripping away. Not a problem until consider it mirrors how affimers were managed. On the plus side Leeds University getnlots of basic science papers published and avacta getva bulk discount on posters.

No agenda. We will get there. Probably at a discount for BP or via another dilution. Always possibility of licensing deal whic h was my most likely scenario until last week Now not so sure but I can pretend otherwise if that's what you need.